You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DFTX Award Disclosure
Wiley Matthew T. · SEC Form 4 · Filed Aug 12, 2026
Award
Calculated transaction value
$0
Wiley Matthew T. Chief Commercial Officer
DFTX
Transaction date
Aug 12, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed same day
DFTX daily price context
Close on/before transaction
$42.79
Aug 12, 2026
First close after public filing
$42.79
Aug 12, 2026
30-day return after filing
-9.11%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 62,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-345836
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Definium Therapeutics, Inc. DFTX Current | Award | Aug 12, 2026 | $0 |